Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
NRF2 is emerging as a major regulator of cellular metabolism. However, most studies have been performed in cancer cells, where co-occurring mutations and tumor selective pressures complicate the influence of NRF2 on metabolism. Here we use genetically engineered, non-transformed primary murine cells...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
eLife Sciences Publications Ltd
2019-05-01
|
| Serija: | eLife |
| Teme: | |
| Online dostop: | https://elifesciences.org/articles/45572 |
| Oznake: |
Brez oznak, prvi označite!
|
